Entegrion Manufacturing, LLC

Entegrion, Inc. is a life sciences company specializing in viscoelastic coagulation monitoring (VCM) systems for rapid hemostasis assessment. The company develops point-of-care diagnostic instruments designed to measure blood coagulation in real-time, enabling clinicians to manage hemostasis and coagulopathies across trauma, surgery, obstetrics, and emergency medicine settings. The VCM system uses fully automated testing with fresh whole blood—no chemical accelerants or sample manipulation required—making it suitable for bedside and pre-hospital applications. The device features a portable footprint optimized for multiple clinical environments. Entegrion's products address both civilian and military medicine needs; the U.S. Department of Defense has invested over $100 million in the company's product development since inception. The VCM has achieved CE Mark regulatory clearance in Europe and other regions accepting CE-marked devices; however, it has not yet received FDA 510(k) clearance for human clinical use in the United States. The company also offers VCMVet for veterinary coagulation monitoring and VCM Cascade for human applications. Leadership includes experienced healthcare executives and clinicians with backgrounds in emergency medicine, hematology, laboratory diagnostics, and transfusion medicine. The organization combines R&D, clinical validation, and regulatory expertise to bring complex laboratory tests to point-of-care settings.